What Is Clover Health Investments, Corp (CLOV) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Clover Health Investments, Corp's intrinsic value is estimated at a composite fair value of $3.16. Trading at $4.57, the stock is approaching fair value or slight overvaluation (implied return of -30.8%), as 9 of 13 models suggest limited further upside. Model dispersion is worth noting: Regime Cross targets $7.54 (+65.1%), versus Markov DDM at $0.30 (-93.4%). This +158.5% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About CLOV?
13 of 13 models are currently active for CLOV. Of these, 4 models suggest upside while 9 models suggest overvaluation. The Bayesian DCF estimates CLOV's intrinsic value at $1.19, implying -74.0% downside from the current price. See which stocks rank higher →
How Does CLOV Rank in Hospital & Medical Service Plans?
Among 9 Hospital & Medical Service Plans stocks, CLOV ranks #9 by Quality of Company score. CirclFi's QOC score of 7.4/10 evaluates 32 fundamental signals. A score of 7.4 indicates above-average quality.
Clover Health Investments, Corp operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is CLOV a Value Trap?
CirclFi's Value Trap algorithm assigns CLOV a score of 6/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for Clover Health Investments, Corp. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, Clover Health Investments, Corp earns a quality score of 7.4/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +158.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every CLOV valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across CLOV's 13 active models, average confidence is 32%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad